Search Results

You are looking at 21 - 30 of 1,744 items for :

  • "chemotherapy" x
Clear All
Full access

Gary H. Lyman

neutropenia hospitalization associated with chemotherapy . Cancer 2005 ; 103 : 1916 – 1924 . 4 Lyman GH Kuderer NM . The economics of the colony-stimulating factors for the prevention and treatment of febrile neutropenia . Crit Rev Oncol

Full access

Nina N. Sanford, Todd A. Aguilera, Michael R. Folkert, Chul Ahn, Brandon A. Mahal, Herbert Zeh, Muhammad S. Beg, John Mansour and David J. Sher

Background Multiple randomized trials have shown improved survival with the addition of adjuvant chemotherapy after surgical resection for patients with pancreatic adenocarcinoma. 1 – 5 In 2000, the NCCN Clinical Practice Guidelines in Oncology

Full access

Jeffrey Crawford, David C. Dale, Nicole M. Kuderer, Eva Culakova, Marek S. Poniewierski, Debra Wolff and Gary H. Lyman

. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients . Cancer 2006 ; 106 : 2258 – 2266 . 3. Hryniuk W Bush H . The importance of dose intensity in chemotherapy of metastatic breast cancer . J Clin Oncol

Full access

Darren R. Feldman, Wendy L. Schaffer and Richard M. Steingart

metastatic disease can be cured with cisplatin-based chemotherapy with or without surgery. Unfortunately, over the past 2 decades, data have emerged linking chemotherapy, particularly cisplatin, with several late toxicities, with cardiovascular disease chief

Full access

Sally Yowell Barbour

.medscape.org/journal/jnccn ; (4) view/print certificate. Release date: April 9, 2012; Expiration date: April 9, 2013. Learning Objectives Upon completion of this activity, participants will be able to: Assess the classification of CINV Distinguish chemotherapy

Full access

Ting Bao

cancer nausea and vomiting . J Clin Oncol 2008 ; 26 : 3903 – 3910 . 2 Hickok JT Roscoe JA Morrow GR . Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of

Full access

William Bensinger, Mark Schubert, Kie-Kian Ang, David Brizel, Elizabeth Brown, June G. Eilers, Linda Elting, Bharat B. Mittal, Mark A. Schattner, Ricardo Spielberger, Nathaniel S. Treister and Andy M. Trotti III

microorganisms and frequently leads to systemic infections. In patients with myelosuppression, grade 3 to 4 mucositis is also associated with a 2-fold increase in emergency room visits and an additional 7 days of hospitalization per chemotherapy cycle. 2 In a

Full access

Jeremy Lund, Angela Pearson and Georgia Keriazes

Background The American Cancer Society estimates that more than 1.6 million new cancer cases were diagnosed in the United States in 2014. 1 Chemotherapy is often an option for the treatment of cancer either alone or as adjunct to radiation or

Full access

Robert E. Smith Jr.

://www.nccn.org . Accessed May 23, 2006 . 4. Kim ES Vokes EE Kies MS . Cetuximab in cancers of the lung and head & neck . Semin Oncol 2004 ; 31 ( suppl 1 ): 61 – 67 . 5. Hryniuk W Levine MN . Analysis of dose intensity for adjuvant chemotherapy

Full access

Sujana Movva, Margaret von Mehren, Eric A. Ross and Elizabeth Handorf

, chemotherapy can be administered in the adjuvant setting with the goal of decreasing the risk of recurrence and improving OS. These goals must be balanced with the potential long-term toxicity. In 1997, the Sarcoma Meta-Analysis Collaboration (SMAC) performed